In the multiple conditional logistic regression analysis from 2003 to 2013, incident HCC risks were independently positively associated with any use of premixed insulin analogues (adjusted OR, 1.27; 95% CI 1.04 to 1.55) before exclusion of patients with chronic viral hepatitis (Table 2). This evidence concerns the gene INS and hepatocellular carcinoma.